- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 25.07. | Reach - Clarifying the narrative | 421 | Reach's interims show it is on track to meet full-year expectations. The statement highlights the new CEO's strategic priorities: driving deeper and broader connections with audiences, accelerating... ► Artikel lesen | ||
| 25.07. | discoverIE Group - Trading in line for Q126 | 481 | In its Q126 trading update, discoverIE confirmed that trading in Q1 was in line with management expectations. Organic revenues were flat year-on-year, showing continued improvement from last year. Following... ► Artikel lesen | ||
| 25.07. | LendInvest - Scalable growth on the horizon | 447 | After a tough year, LendInvest (LINV) has turned a corner and returned to profitability, with H225 PBT turning positive. The mortgage origination division continues to drive the recovery in growth,... ► Artikel lesen | ||
| 25.07. | Wheaton Precious Metals - Q225e preview | 851 | Wheaton Precious Metals' (WPM's) Q225 financial results are scheduled for release on Thursday 7 August, after the market close in Toronto. Ahead of the release, we have updated our forecasts to reflect... ► Artikel lesen | ||
| 24.07. | Victoria - A clearer runway to deliver profit recovery | 296 | Victoria's (VCP's) above-consensus FY25 results show management's self-help initiatives to drive cost savings and operating efficiencies are improving profit margins in still-challenging markets. With... ► Artikel lesen | ||
| 24.07. | Boku - Strong H125 drives upgrades | 348 | Boku expects to report year-on-year revenue growth of 34% for H125, up from the 20% growth reported in FY24, and is guiding to revenue growth of at least 27% for FY25. Both direct carrier billing (DCB... ► Artikel lesen | ||
| 23.07. | Mendus - Strengthened IP profile in ovarian cancer | 385 | Mendus has fortified its intellectual property (IP) profile for lead candidate, vididencel, with the granting of a new US patent covering its use in ovarian cancer (OC). While the lead programme for... ► Artikel lesen | ||
| 23.07. | Aberdeen Asian Income Fund - Strong dividend franchises in quality Asian fund | 365 | Aberdeen Asian Income Fund (AAIF) was launched in 2005 and so far, in its two-decade anniversary year, has experienced some important changes.The board has recently announced the appointment of Isaac... ► Artikel lesen | ||
| 23.07. | Thrive Renewables - More capital, more capacity | 342 | Thrive has a 30-year successful track record, funding 45 wind, solar, storage, tidal and geothermal projects across the UK. As at FY24, Thrive managed £114m of assets and, since inception, has raised... ► Artikel lesen | ||
| 22.07. | Creo Medical - H1 momentum underpins FY25 confidence | 338 | Creo Medical's H125 trading update delivered early results from the company's streamlined focus on its core technology franchise and cost optimisation, following a strategic review in H224. Core technology... ► Artikel lesen | ||
| 22.07. | Templeton Emerging Markets Investment Trust - Strong momentum in core emerging market fund | 312 | Templeton Emerging Markets Investment Trust (TEMIT) has two highly experienced managers, Chetan Sehgal (lead manager) based in Singapore and Andrew Ness based in Edinburgh. They have a clearly defined... ► Artikel lesen | ||
| 17.07. | KEFI Gold and Copper - Code word imminent | 499 | Since our last note at the end of March, KEFI has appointed BCM as its preferred mining contractor and raised £7.6m in equity (supported by Konwave, Phoenix, Premier Miton, RAB and Ruffer, among others)... ► Artikel lesen | ||
| 17.07. | Cereno Scientific - Phase II calling for CS014 after Phase I success | 370 | Cereno Scientific reported positive Phase I readouts for CS014, its novel HDAC inhibitor, paving the way for Phase II studies in idiopathic pulmonary fibrosis (IPF). The candidate demonstrated favourable... ► Artikel lesen | ||
| 15.07. | Baker Steel Resources Trust - High interest in assets, 16.4% return in H125 | 372 | Baker Steel Resources Trust (BSRT) reported a strong monthly NAV uplift of 13.2% in June 2025 (bringing the H125 NAV total return to 16.4%) following its latest interim valuations update, with multiple... ► Artikel lesen | ||
| 15.07. | International Public Partnerships - Operational and financial performance on track | 369 | International Public Partnerships' (INPP's) recent portfolio update showed its portfolio is continuing to perform well, with further progress on accretive capital recycling. INPP shares offer an attractive... ► Artikel lesen | ||
| 15.07. | Zinc Media - Newly defined growth pillars and targets | 376 | Zinc Media continues to win significant new commissions from a wide range of channels and streamers and to build its profile in the market. FY25 market estimates are underpinned by revenues secured... ► Artikel lesen | ||
| 14.07. | Filtronic - £13.4m contract with defence prime | 363 | Filtronic has signed a contract with a defence prime worth £13.4m, with expected delivery from mid-CY26. This contract helps diversify the company's revenue base and highlights progress in the aerospace... ► Artikel lesen | ||
| 11.07. | Greggs - Sales growth slows as the country bakes | 422 | Greggs' H125 trading update showed sales growth slowed in June as high temperatures affected footfall and purchasing patterns. Although the company benefits from sales of cold drinks, including its... ► Artikel lesen | ||
| 11.07. | The Pebble Group - On track, with further tender offer | 328 | Pebble Group's H125 update indicates trading is on track to meet FY25 market expectations, despite a difficult macroeconomic backdrop and currency headwinds. We have made small forecast revisions to... ► Artikel lesen | ||
| 11.07. | Oncodesign Precision Medicine - Precision therapies for resistant diseases | 383 | Oncodesign Precision Medicine (OPM) is a clinical-stage biopharmaceutical company listed on Euronext Growth Paris. OPM is developing precision medicine therapies targeting treatment-resistant and metastatic... ► Artikel lesen | ||
| 11.07. | Oryzon Genomics - KOL event highlights vafidemstat potential in BPD | 369 | At Oryzon Genomics' key opinion leader (KOL) event, vafidemstat's path through Phase III in borderline personality disorder (BPD) was laid out. The significant unmet need was highlighted, as there are... ► Artikel lesen | ||
| 09.07. | Henderson Far East Income - Positioned to benefit as Asia outperforms | 444 | Asian equities have outperformed the US and global markets this year and the manager of Henderson Far East Income (HFEL), Sat Duhra, expects this outperformance to continue, underpinned by a number... ► Artikel lesen | ||
| 09.07. | Solid State - FY26 started positively | 375 | Solid State's FY25 was affected by contract timings. However, FY26 has started positively with a strong order book (+13.9% y-o-y). This suggests the company is back on track, offering a return to the... ► Artikel lesen | ||
| 08.07. | VEON - Catalysts from Kyivstar IPO and buyback | 2.516 | VEON's financial performance at the Q125 stage was strong, and importantly the Ukrainian business that is to be listed in the coming months was solid. Investor attention is now on the Kyivstar IPO,... ► Artikel lesen | ||
| 08.07. | bp - Focusing on returns and growth | 521 | bp is pivoting back towards its traditional upstream oil and gas business, with a renewed focus on shareholder returns. It will remain an integrated energy play with strong differentiating factors (trading... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .